Kinase Inhibitors and Ovarian Cancer

Ovarian cancer is fifth in the rankings of cancer deaths among women, and accounts for more deaths than any other gynecological malignancy. Despite some improvement in overall-(OS) and progression-free survival (PFS) following surgery and first-line chemotherapy, there is a need for development of n...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Katopodis, Periklis, Chudasama, Dimple, Wander, Gurleen, Sales, Louise, Kumar, Juhi, Pandhal, Manreen, Anikin, Vladimir, Chatterjee, Jayanta, Hall, Marcia, Karteris, Emmanouil
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2019
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770231/
https://ncbi.nlm.nih.gov/pubmed/31547471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091357
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы